News for pembrolizumab
- TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival... 16 Jan, 2025
- Adding Pembrolizumab Ups Survival in Stage III... 21 Nov, 2024
- Science Reveals Why Cancer Immunotherapies Can Sometimes... 8 Nov, 2024
- FDA Alert: Keytruda (pembrolizumab) or Tecentriq (atezolizumab): FDA... 18 May, 2018
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
See also
- Biliary Tract Tumor
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Carcinoma
- Gastric Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Hodgkin's Lymphoma
- Malignant Pleural Mesothelioma
- Melanoma
- Melanoma, Metastatic
- Merkel Cell Carcinoma
- Non Small Cell Lung Cancer
- Ovarian Cancer
- Primary Mediastinal Large B-cell Lymphoma
- Renal Cell Carcinoma
- Solid Tumors
- Squamous Cell Carcinoma
- Urothelial Carcinoma

